AN OPEN STUDY ON THE EFFICACY AND SAFETY OF TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE IN TREATING SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA: THE UNIVERSITY OF FLORIDA EXPERIENCE
Authors:
- 1 November 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (5) , 1695-1700
Abstract
We determine the safety and efficacy of transurethral needle ablation of the prostate in patients with moderate to severe symptoms of benign prostatic hyperplasia. Transurethral needle ablation of the prostate was performed on 45 consecutive patients. For an average prostate of 2.5 to 3 cm. long treatments were performed in 2 separate planes at 4 quadrants (2, 4, 8 and 10 o'clock positions) each. The 2 planes were 1 cm. below the bladder neck and 1 cm. proximal to the verumontanum. For prostatic urethral lengths longer than 3 cm. a treatment plane was added for each additional centimeter of prostatic urethra. The procedure was performed in 26 patients under local anesthesia using 20 cc 2% intraurethral lidocaine gel (11) or supplemented with intravenous 1.25 to 5 mg. midozolam (15). Of these patients 2 had a supplemental perineal block using a mixture of equal amounts of 15 cc 2% lidocaine without epinephrine and 0.25% bripivacaine, 10 underwent the procedure under general anesthesia, 2 had epidural and 4 had spinal anesthesia, and 3 had managed anesthesia care. Mean length of each procedure was 79 minutes (range 50 to 240). All procedures were done on an outpatient basis and patients were released on the same operative day. Mean prostatic volume on transrectal ultrasound was estimated at 48.1 cc (range 20 to 185). Following treatment the International Prostate Symptom Score decreased from a mean of 20.9 at baseline to 15.4 at 1 month, 16.1 at 3 months, 10.7 at 6 months and 9.9 at 1 year. The peak flow rate improved from a baseline mean of 8.3 to 13.4 at 3 months, 13.1 at 6 months and 14.9 at 1 year. The quality of life score improved from a baseline of 4.8 to 3.5, 2.2, 2.5 and 1.03 at 1, 3, 6 and 12 months, respectively. Of the 2 patients in whom the procedure failed; 1 required a bladder neck incision at 3 months and the other transurethral resection of the prostate. Foley catheters were left in place in all patients for an average of 4.85 days. After a followup of up to 12 months we conclude that transurethral needle ablation of the prostate is an effective treatment for symptomatic benign prostatic hyperplasia. This procedure has minimal morbidity, is less costly than conventional transurethral resection of the prostate and can be performed as an outpatient office procedure under local anesthesia in a significant number of patients.Keywords
This publication has 11 references indexed in Scilit:
- Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. studyUrology, 1998
- Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluationUrology, 1997
- Possible Mechanisms of Action of Transurethral Needle Ablation of the Prostate on Benign Prostatic Hyperplasia Symptoms: A Neurohistochemical StudyJournal of Urology, 1997
- Transurethral Needle Ablation of the Prostate: Report of Initial United States Clinical TrialJournal of Urology, 1996
- Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experienceUrology, 1995
- Transurethral Needle Ablation (TUNA): Safety, Feasibility, and Tolerance of a New Office Procedure for Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1993
- Transurethral Needle Ablation (TUNA) of the Prostate Using Low-Level Radiofrequency Energy: An Animal Experimental StudyEuropean Urology, 1993
- Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome.Circulation, 1992
- Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 PatientsJournal of Urology, 1989
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984